Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the tr…
$0.84+6.54%
报价 2026-11-06
市值
$95.9M
EV
$264.5M
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -85.1%
$0.79$5.65
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| CATXPerspective Therapeutics, Inc. | $95.9M | +6.5% | -54.5% | -419.4% | – | – | – | |
| AVRAnteris Technologies Global Corp. | $554.5M | +2.0% | – | 28.2% | – | – | – | |
| PROFProfound Medical Corp. | $263.4M | +4.8% | – | 71.7% | – | – | – | |
| ELMDElectromed, Inc. | $225.2M | +1.5% | – | – | – | – | – | |
| TLSITriSalus Life Sciences, Inc. | $200.1M | -7.9% | +19.9% | 85.8% | – | – | – | |
| IVVDInvivyd, Inc. | $165.9M | -3.8% | +64.0% | 91.4% | – | – | – | |
| STIMNeuronetics, Inc. | $163.8M | -11.5% | +8.8% | 50.7% | – | – | – | |
| MXCTMaxCyte, Inc. | $130M | -3.8% | -11.4% | 79.4% | – | – | – | |
| HSDTTessera Defense and Homeland Security Inc | $112.7M | -8.1% | +3075.0% | 95.5% | – | – | – | |
| 同行中位数 | – | – | +19.9% | 79.4% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。